Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000019.xml
Fortschr Neurol Psychiatr 2011; 79(10): 598-606
DOI: 10.1055/s-0031-1281721
DOI: 10.1055/s-0031-1281721
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York
Metabolische Myopathien – Teil I: Störungen des Kohlehydratstoffwechsels
Metabolic Myopathies – Part I: Disorders of the Carbohydrate MetabolismFurther Information
Publication History
Publication Date:
11 October 2011 (online)
![](https://www.thieme-connect.de/media/fdn/201110/lookinside/thumbnails/10.1055-s-0031-1281721-1.jpg)
Lernziele
Diese Übersicht über metabolische Myopathien ist in 2 Teile gegliedert. Ziel dieses ersten Teiles ist es, einen kurzen Überblick über Ursache, Klinik, Diagnose und Therapie der wichtigsten metabolischen Myopathien, bedingt durch Störungen des Kohlehydratstoffwechsels, zu geben.
Literatur
- 1 DiMauro S, Garone C, Naini A. Metabolic myopathies. Curr Rheumatol Rep. 2010; 12 386-393
- 2 Hermans M C, Pinto Y M, Merkies I S et al. Hereditary muscular dystrophies and the heart. Neuromuscul Disord. 2010; 20 479-492
- 3 Dehnert C, Bärtsch P. Diagnostik metabolischer Myopathien. Dtsch Z Sportmed. 2005; 56 179-180
- 4 Ørngreen M C, Jeppesen T D, Andersen S T et al. Fat metabolism during exercise in patients with McArdle disease. Neurology. 2009; 72 718-724
- 5 Das A M, Steuerwald U, Illsinger S. Inborn errors of energy metabolism associated with myopathies. J Biomed Biotechnol. 2010; 2010 340 849
- 6 Kazemi-Esfarjani P, Skomorowska E, Jensen T D et al. A nonischemic forearm exercise test for McArdle disease. Ann Neurol. 2002; 52 153-159
- 7 Zilokowska-Graca B, Kania A, Zwolinska G et al. Adult form of Pompe disease. Pneumonol Alergol Pol. 2008; 76 396-399
- 8 Ploeg A T, Clemens P R, Corzo van der D et al. A randomized study of alglucosidase alfa in late-onset Pompe’s disease. N Engl J Med. 2010; 362 1396-1406
- 9 Kishnani P S, Goldenberg P C, DeArmey S L et al. Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab. 2010; 99 26-33
- 10 Mendelsohn N J, Messinger Y H, Rosenberg A S et al. Elimination of antibodies to recombinant enzyme in Pompe’s disease. N Engl J Med. 2009; 360 194-195
- 11 Parenti G. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. EMBO Mol Med. 2009; 1 268-279
- 12 Kotb M A, Abdallah H K, Kotb A. Liver glycogenoses: are they a possible cause of polyneuropathy? A cross-sectional study. J Trop Pediatr. 2004; 50 196-202
- 13 Mundy H R, Williams J E, Lee P J et al. Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit. J Inherit Metab Dis. 2008; 31 418-423
- 14 Endo Y, Horinishi A, Vorgerd M et al. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. J Hum Genet. 2006; 51 958-963
- 15 Aoyama Y, Ozer I, Demirkol M et al. Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R 1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations. J Hum Genet. 2009; 54 681-686
- 16 Dagli A I, Zori R T, McCune H et al. Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet. J Inherit Metab Dis. 2009; 32 1-4
- 17 Nadaj-Pakleza A A, Vincitorio C M, Laforêt P et al. Permanent muscle weakness in McArdle disease. Muscle Nerve. 2009; 40 350-357
- 18 Stojkovic T, Vissing J, Petit F et al. Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med. 2009; 361 425-427
- 19 Kollberg G, Tulinius M, Gilljam T et al. Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0. N Engl J Med. 2007; 357 1507-1514
- 20 Moslemi A R, Lindberg C, Nilsson J et al. Glycogenin-1 deficiency and inactivated priming of glycogen synthesis. N Engl J Med. 2010; 362 1203-1210
Josef Finsterer, MD, PhD
Postfach 20
1180 Wien
Österreich
Email: fifigs1@yahoo.de